Discovery of a novel, orally available, transient receptor potential channel 6 inhibitor Aug. 28, 2018
GNE-684: a potent inhibitor of RIPK1 for treating inflammatory diseases due to dysregulated NEMO Aug. 22, 2018
BRD4 inhibitors patented by Luoxin Biotechnology Shanghai, Shandong Luoxin Pharmacy Group July 30, 2018
RSS